BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24535607)

  • 1. The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy.
    Huang J; Xu L; Luo Y; He F; Zhang Y; Chen M
    Med Oncol; 2014 Apr; 31(4):883. PubMed ID: 24535607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
    Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
    World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    He CB; Lin XJ
    PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
    Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y
    Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma.
    Ni XC; Yi Y; Fu YP; He HW; Cai XY; Wang JX; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    Medicine (Baltimore); 2015 Sep; 94(36):e1486. PubMed ID: 26356714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).
    Pinato DJ; Stebbing J; Ishizuka M; Khan SA; Wasan HS; North BV; Kubota K; Sharma R
    J Hepatol; 2012 Nov; 57(5):1013-20. PubMed ID: 22732513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.
    Yamamura K; Sugimoto H; Kanda M; Yamada S; Nomoto S; Nakayama G; Fujii T; Koike M; Fujiwara M; Kodera Y
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):682-8. PubMed ID: 24823966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.
    Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y
    Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Fushiya N; Koike K; Nishino H; Tajiri H
    Br J Cancer; 2012 Sep; 107(6):988-93. PubMed ID: 22878374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article.
    Fu YP; Ni XC; Yi Y; Cai XY; He HW; Wang JX; Lu ZF; Han X; Cao Y; Zhou J; Fan J; Qiu SJ
    Medicine (Baltimore); 2016 Feb; 95(7):e2784. PubMed ID: 26886627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
    Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
    J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy.
    Huang J; Zhang Y; Peng Z; Gao H; Xu L; Jiao LR; Chen M
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1709-19. PubMed ID: 23982274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M; Saeki C; Tajiri H
    BMC Cancer; 2013 Feb; 13():52. PubMed ID: 23374755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE.
    Lu LH; Wei W; Li SH; Zhang YF; Guo RP
    Aging (Albany NY); 2021 Feb; 13(4):5358-5368. PubMed ID: 33589570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.
    Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R
    J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onodera's prognostic nutritional index is a strong prognostic indicator for patients with hepatocellular carcinoma after initial hepatectomy, especially patients with preserved liver function.
    Tanemura A; Mizuno S; Hayasaki A; Gyoten K; Fujii T; Iizawa Y; Kato H; Murata Y; Kuriyama N; Kishiwada M; Sakurai H; Isaji S
    BMC Surg; 2020 Oct; 20(1):261. PubMed ID: 33129309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.